Not applicableUnknownNCT04895007What this trial is testingComparative Evaluation of Covid-19 Vaccines ResponseWho this might be right forCOVID-19 Vaccines Karamanoğlu Mehmetbey University 1,500
Not applicableEnded earlyNCT04870411What this trial is testingImmunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or BiologicsWho this might be right forAutoimmune DiseasesInflammatory Disorder Assistance Publique - Hôpitaux de Paris 78
Not applicableLooking for participantsNCT05571735What this trial is testingImmunogenicity of COVID-19 Vaccines in Tuberculosis PatientsWho this might be right forCovid-19 PandemicsTuberculosis University of Oxford 133
Testing effectiveness (Phase 2)WithdrawnNCT05950776What this trial is testingCOVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in AdultsWho this might be right forCovid19 Universitätsklinikum Hamburg-Eppendorf
Not applicableUnknownNCT05126550What this trial is testingThe Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated VaccineWho this might be right forCOVID-19 PT. Kimia Farma (Persero) Tbk 435
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07567274What this trial is testingDMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine InjuryWho this might be right forTinnitus Leading Edge Clinic 20
Early research (Phase 1)Study completedNCT07095231What this trial is testingSafety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in AdultsWho this might be right forCOVID-19 National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)UnknownNCT05329051What this trial is testingEvaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 YearsWho this might be right forSARS-CoV-2 InfectionCOVID-19 Sinocelltech Ltd. 400
Not applicableStudy completedNCT05185687What this trial is testingPublic Support for COVID-19 Test AllocationWho this might be right forHealth EquityCOVID-19 University of Pennsylvania 2,019
Early research (Phase 1)UnknownNCT05007275What this trial is testingDetermine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult VolunteersWho this might be right forCovid19SARS-CoV-2 Infection Imperial College London 28
Not applicableStudy completedNCT05121662What this trial is testingCOVID-19 Vaccine Biomarker Study in Multiple SclerosisWho this might be right forMultiple SclerosisCOVID-19 Columbia University 154
Large-scale testing (Phase 3)Study completedNCT04470427What this trial is testingEvaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19Who this might be right forSARS-CoV-2 ModernaTX, Inc. 30,415
Not applicableStudy completedNCT06597370What this trial is testingImmunogenicity Induced by COVID-19 Vaccines in Mexican PopulationWho this might be right forCOVID-19 Vaccine National Polytechnic Institute, Mexico 80
Post-approval studies (Phase 4)Study completedNCT04852861What this trial is testingCOVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 VaccineWho this might be right forCovid19 Sciensano 145
Early research (Phase 1)Ended earlyNCT04569786What this trial is testingDose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)Who this might be right forCoronavirus Disease (COVID-19) Merck Sharp & Dohme LLC 232
Post-approval studies (Phase 4)UnknownNCT05105295What this trial is testingImmunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV InfectedWho this might be right forCOVID-19HIV Infections China National Biotec Group Company Limited 400
Testing effectiveness (Phase 2)Study completedNCT06695130What this trial is testingStudy of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and OlderWho this might be right forCOVID-19 ImmunizationInfluenza Immunization Sanofi 980
Not applicableStudy completedNCT06113692What this trial is testingA Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 VaccineWho this might be right forMyocarditis, Pericarditis ModernaTX, Inc. 1,169
Not applicableUnknownNCT05150834What this trial is testingGut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 VaccinesWho this might be right forMicrobiomeVaccineCovid-19+2 more Korea University Guro Hospital 53
Testing effectiveness (Phase 2)WithdrawnNCT05663086What this trial is testingImmunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and AboveWho this might be right forCOVID-19 Guangzhou Patronus Biotech Co., Ltd.